Rocket Doctor Announces First in Canada Strategic Partnership with Toronto Metropolitan University to Support Clinical Education of Medical Learners on a Digital Health Platform
Rhea-AI Summary
Rocket Doctor AI (OTC: AIRDF) announced a strategic partnership with Toronto Metropolitan University on December 4, 2025 to support clinical education using Rocket Doctor’s digital health platform.
Under the agreement, Rocket Doctor will promote clinical faculty appointments, verify physician status, facilitate learner observation (including virtual care), and coordinate physician applications. TMU will define faculty responsibilities, oversee placements, and maintain learning quality. The collaboration aims to expand teaching capacity across urban and underserved regions and modernize clinical training for medical learners in Ontario and Canada.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, AIRDF gained 1.96%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Market Reality Check
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | AI pilot partnership | Positive | -5.7% | AI-powered clinical decision support pilot with CAN Health and Health Cities in Alberta. |
| Dec 05 | CFO change & awards | Neutral | -5.7% | Interim CFO appointment plus stock option and RSU grants to leadership and consultants. |
| Dec 04 | Education partnership | Positive | +2.0% | Strategic partnership with TMU to expand clinical education via Rocket Doctor platform. |
| Dec 02 | Q3 2025 results | Positive | +1.2% | Q3 revenue growth, 88% gross margin, expanded payer reach and NIH SBIR funding. |
| Nov 26 | Conference visibility | Positive | +9.6% | CEO presentations at Google Accelerator Alumni event and Heal.LA Demo Day highlighting AI use. |
Across the last five news events, price mostly aligned with positive catalysts, though two recent announcements saw negative reactions despite constructive or neutral content.
This announcement on Dec 4, 2025 extends Rocket Doctor AI’s strategy of leveraging its digital health platform through partnerships and visibility events. Recent news includes Q3 2025 results showing sequential revenue growth and strong 88% gross margin, AI-focused pilots in Alberta, and high-profile presentations with Google and Heal.LA. A management change and equity grants on Dec 5, 2025 added governance and compensation updates. Together, these releases highlight growth, commercialization, and ecosystem-building around its virtual care and AI offerings.
Market Pulse Summary
This announcement detailed a strategic partnership with Toronto Metropolitan University to use Rocket Doctor’s digital health platform for clinical education, mentorship, and learner placements across Canada. It complements recent milestones in revenue growth, AI pilots, and ecosystem visibility. Investors may watch how many physicians and learners ultimately participate, how virtual care is integrated into training, and how these academic relationships support longer-term platform utilization and recognition.
Key Terms
digital health platform technical
clinical education medical
clinical faculty medical
virtual care medical
AI-generated analysis. Not financial advice.
- Rocket Doctor and Toronto Metropolitan University (TMU) have formed a strategic partnership to leverage the independent physicians on the Rocket Doctor platform to expand clinical education opportunities across TMU’s Medical School.
- Both organizations will collaborate on joint communications and create streamlined pathways for physicians on Rocket Doctor to engage with TMU and apply for clinical faculty roles.
- Rocket Doctor will promote and facilitate clinical faculty appointments, verify physician status, support learner observation on its platform, and help coordinate physician interest and applications.
- TMU will work directly with participating physicians to define responsibilities, oversee learner placements, and maintain high-quality clinical learning environments.
- The partnership aims to strengthen and expand the teaching capacity of Ontario’s healthcare workforce by connecting physicians on a digital health platform with meaningful opportunities to mentor the next generation of learners.
Vancouver, BC, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) wholly-owned digital health platform and marketplace Rocket Doctor Inc. (“Rocket Doctor”) today announced a new partnership with Toronto Metropolitan University (TMU) designed to accelerate physician recruitment, promote clinical faculty opportunities, and enhance learner placements with independent physicians on the platform across Canada.
The partnership is designed to strengthen TMU’s clinical teaching ecosystem by making clinical faculty participation more accessible to practising physicians in the community across the country. Rocket Doctor’s uniquely distributed network allows TMU to reach clinicians across both urban and underserved regions, helping to create a wider pool of educators and a richer learning environment for medical trainees. By integrating opportunities for learner observation and mentorship across different care settings, including virtual care, the collaboration supports TMU’s vision of preparing future physicians to deliver care in diverse, technology-enabled environments.
“This collaboration reflects our shared belief that medical education should be community-driven, accessible, and deeply connected to how care is delivered today,” said Dr. Bill Cherniak, Founder & CEO of Rocket Doctor Inc.. “By opening new doors for physicians to teach and mentor, we’re helping to build a stronger pipeline of clinicians who will serve learners at TMU for decades to come.”
TMU will work directly with participating physicians to ensure they have the academic guidance, resources, and support needed to deliver meaningful educational experiences. The partnership places strong emphasis on creating positive learning environments, promoting consistent communication between clinical partners and TMU clinical faculty, and ensuring learners are supported as they transition between different care settings. The result is a more flexible, modernized clinical education system that reflects the realities of today’s healthcare landscape.
“We are thrilled to partner with Rocket Doctor as we continue to build a medical education model that reflects the reality of modern healthcare,” said Dr. Teresa Chan, Founding Dean at TMU School of Medicine. “By engaging physicians who practise across diverse communities and care settings, including virtual care, we are expanding the perspectives and experiences available to our learners. This collaboration will help us prepare future physicians who are adaptable, community-minded, and ready to meet the evolving needs of Ontario’s health system.”
This partnership is rooted in a shared commitment to enhancing Ontario’s clinical education landscape by connecting academic programs with the clinicians delivering care every day across the country. By uniting TMU’s forward-looking approach to medical training with Rocket Doctor’s extensive Canada-wide network, the collaboration aims to build a more resilient healthcare workforce and expand access to care, particularly in rural and remote communities. Together, the organizations will provide learners with exposure to diverse clinical environments while creating new pathways for physicians to take on mentorship, leadership, and academic roles.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc’s products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
FAQ
What did Rocket Doctor (AIRDF) announce on December 4, 2025 with Toronto Metropolitan University?
How will the Rocket Doctor–TMU partnership affect clinical faculty recruitment for AIRDF?
Will Rocket Doctor (AIRDF) support virtual care observation for TMU learners?
What role will TMU play in the partnership with Rocket Doctor (AIRDF)?
Does the partnership between Rocket Doctor (AIRDF) and TMU target rural or underserved regions?
